CORC

在结果中检索

CORC

浏览/检索结果: 共25条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China 期刊论文
THORACIC CANCER, 2021
作者:  Shi, Yuequan;  Fang, Jian;  Zhou, Chengzhi;  Liu, Anwen;  Wang, Yan
收藏  |  浏览/下载：64/0  |  提交时间：2022/01/25
D-0316 in patients with advanced T790M-positive EGFR-mutant non-small cell lung cancer who progressed on prior EGFR-TKI therapy: results from a phase II study (NCT03861156). 期刊论文
CANCER RESEARCH, 2021, 卷号: 81
作者:  Lu, Shun;  Zhang, Yiping;  Zhang, Guojun;  Zhou, Jianying;  Cang, Shundong
收藏  |  浏览/下载：58/0  |  提交时间：2021/11/01
Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial 期刊论文
LANCET RESPIRATORY MEDICINE, 2018, 卷号: Vol.6 No.9, 页码: 681-690
作者:  Wang, Zhijie;  Cheng, Ying;  An, Tongtong;  Gao, Hongjun;  Wang, Kai
收藏  |  浏览/下载：3/0  |  提交时间：2019/02/25
Establishment of a prospective multicenter cohort for advanced non-small cell lung cancer in China (CAPTRA-Lung study) 期刊论文
2018, 卷号: 9, 期号: 12, 页码: 1795-1800
作者:  Xu, Yan;  Zhang, Li;  Fang, Jian;  Wang, Ziping;  Li, Junling
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/03
Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial 期刊论文
2018, 卷号: 6, 期号: 9, 页码: 681-690
作者:  Wang, Zhijie;  Cheng, Ying;  An, Tongtong;  Gao, Hongjun;  Wang, Kai
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
Confined Pyrolysis for Simulating Hydrocarbon Generation from Jurassic Coaly Source Rocks in the Junggar Basin, Northwest China 期刊论文
Energy & Fuels, 2017, 卷号: 31, 期号: 1, 页码: 73-94
作者:  Xu, Hao;  Ding, Xianghua;  Luo, Zhengjiang;  Liu, Cuimin;  Li, Erting
收藏  |  浏览/下载：20/0  |  提交时间：2018/09/03
A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2017, 卷号: 12, 期号: 1
作者:  Zhao, Yizhuo;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua;  Wang, Zhehai
收藏  |  浏览/下载：14/0  |  提交时间：2019/12/04
China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version) 期刊论文
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 卷号: 13, 期号: 1
作者:  Li, Xiaomei;  Shi, Yuankai;  Sun, Yan;  Yu, Jinming;  Ding, Cuimin
收藏  |  浏览/下载：18/0  |  提交时间：2019/12/05
China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version) 期刊论文
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 卷号: 13, 期号: 1
作者:  Feng, Jifeng;  Shi, Yuankai;  Sun, Yan;  Yu, Jinming;  Ding, Cuimin
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version) 期刊论文
Asia‐Pacific Journal of Clinical Oncology, 2017, 卷号: 13, 期号: 1, 页码: 87-103
作者:  Shi, Yuankai*;  Sun, Yan;  Yu, Jinming;  Ding, Cuimin;  Wang, Ziping
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/03

©版权所有 ©2017 CSpace - Powered by CSpace